Insulin and glucagon degradation by the kidney. I. Subcellular distribution under different assay condition
- PMID: 8105
- DOI: 10.1016/0304-4165(76)90020-9
Insulin and glucagon degradation by the kidney. I. Subcellular distribution under different assay condition
Abstract
Insulin and glucagon degradation by rat kidney homogenates and subcellular fractions was examined under a variety of conditions including high and low substrate concentrations, at pH 4 and pH 7, with and without glutathione. At high insulin concentration (4.1 - 10(-5) M) insulin degradation by the homogenate was greatest at pH 4 but at low insulin concentration (1 - 10(-10) M) insulin degradation was greatest at pH 7. At either high or low glucagon concentration glucagon degradation by the homogenate was greatest at pH 7. Glutathione at pH 7 stimulated insulin degradation at high insulin concentrations and inhibited insulin degradation at low concentrations; Glucagon degradation at pH 7 was inhibited at both high and low concentrations of glucagon by glutathionemseparation of kidney into cortex and medulla prior to homogenation produced a pattern of insulin and glucagon degradation identical to the whole homogenate but glucagon degradation by the medulla was greater than by the cortex. Examination of degradation by subcellular fractions revealed that at high concentration at neutral pH most insulin was degraded by the 100 000 X g pellet but at low insulin concentrations over 90% of the activity was in the 100 000 X g supernatant; At pH 7, at both high and low concentrations, most glucagon-degrading activity was in the 100 000 X g pellet, although the cytosol also had activity; At pH 4 most degradation occurred in the lysosomal fractions. Separation into cortex and medulla again showed similar distribution of activity as the whole gland with the medulla having more glucagon-degrading activity than the cortex. With low insulin concentrations the cortex 100 000 X g supernatant had higher relative specific activities than the medulla supernatant. Examination of recoveries of enzyme activity revealed that the subcellular fractions consistently had markedly less insulin-degrading activity than the original homogenate. This loss of activity was only discernible when insulin degradation was performed at pH 7 at low substrate concentrations. Comparable losses of glucagon-degrading activity were not seen.
Similar articles
-
Insulin and glucagon degradation by the kidney. II. Characterization of the mechanisms at neutral pH.Biochim Biophys Acta. 1976 Jul 21;437(2):531-42. doi: 10.1016/0304-4165(76)90021-0. Biochim Biophys Acta. 1976. PMID: 8106
-
Proteolytic degradation and modification of rat prolactin by subcellular fractions of the rat ventral prostate gland.Endocrinology. 1984 Aug;115(2):476-84. doi: 10.1210/endo-115-2-476. Endocrinology. 1984. PMID: 6378591
-
Insulin degradation by human skeletal muscle.Biochim Biophys Acta. 1982 Nov 24;719(2):259-66. doi: 10.1016/0304-4165(82)90097-6. Biochim Biophys Acta. 1982. PMID: 6758860
-
Subcellular localization and preliminary characterization of islet hormone-degrading activities in anglerfish islet tissue.Gen Comp Endocrinol. 1983 Mar;49(3):414-27. doi: 10.1016/0016-6480(83)90205-8. Gen Comp Endocrinol. 1983. PMID: 6341166
-
Glucagon degradation by luminal and basolateral rabbit tubular membranes.Am J Physiol. 1983 Mar;244(3):F297-303. doi: 10.1152/ajprenal.1983.244.3.F297. Am J Physiol. 1983. PMID: 6829762
Cited by
-
Time-course of insulin degradation in perifused isolated rat adipose cells.J Clin Invest. 1980 Feb;65(2):461-8. doi: 10.1172/JCI109689. J Clin Invest. 1980. PMID: 7356690 Free PMC article.
-
The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE.Viruses. 2018 Dec 12;10(12):710. doi: 10.3390/v10120710. Viruses. 2018. PMID: 30545091 Free PMC article.
-
Hepatic Insulin Clearance: Mechanism and Physiology.Physiology (Bethesda). 2019 May 1;34(3):198-215. doi: 10.1152/physiol.00048.2018. Physiology (Bethesda). 2019. PMID: 30968756 Free PMC article. Review.
-
Splanchnic and Leg Glucagon Metabolism in Healthy Individuals and Those With Type 1 Diabetes: First-in-Human Study Using [13C9,15N1]Glucagon.Diabetes. 2025 Aug 1;74(8):1342-1354. doi: 10.2337/db24-1064. Diabetes. 2025. PMID: 40445879 Free PMC article.
-
The renal metabolism of insulin.Diabetologia. 1984 Sep;27(3):351-7. doi: 10.1007/BF00304849. Diabetologia. 1984. PMID: 6389240 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources